Get 10 Free Leads on us
Use our Chrome Extension & instantly connect with prospects
Chulbeom Kim
PharmAbcine
Profile privacy
According to Datanyze information, these are Chulbeom Kim's contact details. Reveal the hidden information below for FREE!
Phone (Direct)
+82 42 ❅❅❅ ❅❅❅❅
Phone (Direct)
Phone (Mobile)
+82 70 ❅❅❅❅ ❅❅❅❅
Phone (Mobile)
Phone (HQ)
+82 428612017
Phone (HQ)
❅❅❅❅❅@pharmabcine.com
❅❅❅❅❅@gmail.com
Office Address (HQ)
Research Building 2 70 Yuseong-daero 1689 Beon-Gil Yuseong-gu 2F, Daejeon Daejeon, 34047, South Korea
Office Address (HQ)
Chulbeom Kim works as a Chief Financial Officer at PharmAbcine, which is a Business Services company with an estimated 106 employees; and founded in 2008. They are part of the Finance Executive team within the C-Suite Department and their management level is C-Level. Chulbeom is currently based in Daejeon, South Korea. They used to work at Sogang University and Hanwha Investment & Securities Co., Ltd and have used the following emails: @pharmabcine.com.
Remember this info to help warm up your cold call with Chulbeom! ❄️
Chulbeom Kim's career began less then a year ago. Prior to joining PharmAbcine, Chulbeom worked at 7 companies.
Independent Consultant
Professor - Corporate Finance
Head Senior Managing Director, Research
Woori Asset Management
Chief Investment Officer & Senior Managing Director
Head Managing Director, Research
Korea Investment Trust Management Co., LTD
Head Managing Director, Research
Chief Investment Officer, Equity & Director
PharmAbcine
Research Building 2 70 Yuseong-daero 1689 Beon-Gil Yuseong-gu 2F, Daejeon Daejeon, 34047, South Korea
106
$14.2 M
Business Services, Research & Development
Get Full Profile Access
Ice Breakers
Imagine you could know all about PharmAbcine - Chulbeom Kim’s company, before you contact them. Warm up a cold prospect with Datanyze icebreakers
Chulbeom’s company in the news
PharmAbcine Announces Safety Approval for the First Dose Cohort in Phase 1a/b Clinical Trial of PMC-309 in Patients with Advanced or Metastatic Solid Tumors
July 8, 2024
PharmAbcine's Phase 1 Clinical Trial of PMC-403 for Neovascular Age-related Macular Degeneration Advances to Both Single-dose of 4mg and Multiple-dose of 3mg
July 2, 2024
PharmAbcine's U.S. Subsidiary, Wincal Biopharm, Presented Preclinical Data on Eye Drops from its Proprietary OPC Platform at ARVO 2024
May 23, 2024
See more
Insights to Break the Ice
In your first interaction
Chulbeom’s CEO is Yoo San
Chulbeom is located in South Korea
PharmAbcine’s Funding
Last funding
$6M
August 31, 2009
Total raised
$6M
Work Colleague
See Chulbeom Kim's coworkers out of PharmAbcine's 106 employees
| Name & Title | Contact Info | |
|---|---|---|
Yoo San Chief Executive Officer | Reveal for Free | |
Chulbeom Kim Chief Financial Officer |
| Reveal for Free |
Sang Shim Director of CMC Department |
| Reveal for Free |
Bo Jeong General Manager, Process Development |
| Reveal for Free |
Weon Lee Center of Pharmabcine Head of Research & Development |
| Reveal for Free |
Hyojin Koh Clinical Development Head |
| Reveal for Free |
Sookyoung Shin Head |
| Reveal for Free |
Jinhee Choi Assistant Manager | Reveal for Free |
Start with Datanyze For Free!
Find your B2B customer within minutes using affordable, accurate contact data from Datanyze
Try it free
